ERBB2 and breast neoplasm: Using clinically annotated gene expression datasets (n = 310, TCGA; [18]), we found that TUBB2B mRNA is upregulated in 26% of TNBC cases, compared to 3% and 1.3% in luminal and HER2 + breast tumors, respectively (Fig. 1A).